GovChime
Notice ID: 6475d69e5a312968b58d96808f7057e1Award NoticeAwarded

INHALANT (RED) MULTI-ALLERGEN

Awarded on June 17, 2019. Full description on SAM.gov.

Awarded tounder N0025919P0334 (source: SAM.gov award notice)• $90.7K

Overview

Posted
June 17, 2019
Notice type
Award Notice
Agency
Department of WarDepartment of the Navy

Notice details

Office
NAVAL MEDICAL CENTER SAN DIEGO CA
Place of performance
SUPPLY OFFICER (N68470) US NAVAL HOSPITAL OKINAWA CAMP FOSTER BLDG 966 TARAWA ROAD GINOWAN SHI, ISA , Okinawa, 901-221
PSC
65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Last updated
Dec 4, 2025
Award date
Jun 17, 2019
Award amount (SAM.gov award notice)
$90.7K

Identifiers

Solicitation number
N0025919N0055
Notice ID
6475d69e5a312968b58d96808f7057e1
Award number (PIID)
N0025919P0334

Description

Notice of Intent to Sole Source THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. Reference#: N0025919N0055 US Naval Hospital Okinawa (USNHO) intends to award a firm fixed price sole source contract under the authority of FAR 13.106-1(b)(1)(i), only one source being available to meet the Government's needs, to: Allergychoices, Inc. 2731 National Drive Onalaska, WI, 54650-8784 The North American Industry Classification System (NAICS) code for this requirement is 325412; the business size standard is 1250 (# of employees). The objective of this sole source award is to procure Sublingual Immunotherapy Drops used to support patients with allergic rhinitis in support of US Naval Hospital Okinawa (USNHO). The requirement is for 140 INHALANT (RED) MULTI-ALLERGEN with delivery schedule from June 30, 2019 to June 29, 2020 (Base Year) plus four (4) option years. Allergychoices, Inc is the only source that can provide the immunotherapy plans specifically tailored to each patient. Patients are enrolled in an immunotherapy care plan that takes up to 5 years to complete. USNH Okinawa (USNHO) cannot switch to another medication provider and interrupt ongoing patient care because of contracting restrictions. Treatment is an ongoing process for 30-40 patients currently enrolled in immunotherapy care plan. Patients are placed on a specific treatment protocol with new vials of drops provide every 3 months. The process of vetting new companies, requiring in having to repeat allergy testing and obtain new vials of drops for every patient would negatively result in a break of therapy for all . This compromises the effectiveness of treatment and poses a significant setback for patients relying on allergy therapy to control their symptoms. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work and are able to provide valid certification to provide Sublingual Immunotherapy Drops validated by Allergychoices, Inc. Capability statements shall not exceed 6 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 1200 PM Local Time, June 03, 2019. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: mildred.k.pollard-hueitt.civ@mail.mil . The email subject line shall state, "US Naval Hospital Okinawa (USNHO), Special Notice Number N0025919N0055." NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED

Full description on SAM.gov

Award Overview

Award Number

N0025919P0334

Award Amount (SAM.gov award notice)

$90.7K

Award Date

Jun 17, 2019

Awardee

Awardee UEI

PUT2SZMMXHM5

Original Solicitation

Notice ID: 6475d69e5a312968b58d96808f7057e1

Posted Date: Jun 17, 2019

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

3
  • HT941024P0177
    ALLERGYCHOICES LLC
    Department of DefenseNAICS 325412
    $22.4KSigned Dec 17, 2025
  • HT941024P0177
    ALLERGYCHOICES LLC
    Department of DefenseNAICS 325412
    $17.9KSigned Sep 11, 2025
  • HT001423A0009
    ALLERGYCHOICES LLC
    Department of DefenseNAICS 325412
    —Signed Mar 14, 2025

Contacts

Documents

No documents available.

Lifecycle

Solicitation:N0025919N0055
  1. Awarded

This opportunity has been awarded.

  1. Special NoticeMay 9, 2019

    INHALANT (RED) MULTI-ALLERGEN

    Notice cdc42bcdeb259af92fb3dd0c439fba04 on SAM.gov

  2. AwardedCurrentJun 17, 2019

    INHALANT (RED) MULTI-ALLERGEN

    Notice 6475d69e5a312968b58d96808f7057e1 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

N0025919N0055

Archive Date

Jul 2, 2019

Place of Performance Country

JPN

Office Address

SAN DIEGO, CA, 92134-5000